We examined whether TTL depletion was a bona fide feature of neurodegenerative disease and found that TTL was downregulated in both sporadic and familial Alzheimer disease, and that abnormally high levels of detyrosinated and Δ2 tubulins accumulated in brain samples of Alzheimer’s disease patients. This evidence concerns the gene TTL and neurodegenerative disease.